乳房病変局在化の世界市場2023-2030

乳房病変局在化の世界市場規模は、2022年に4億8,000万米ドルと評価され、予測期間（2023-2030年）に7.8%のCAGRを記録して、2030年までに8億1,200万米ドルに達すると予測されています。世界の乳房病変局在化市場は、全世界で乳がんの有病率が上昇していることから、予測期間中に大きな成長が見込まれます。触知可能な乳房病変や触知不可能な乳房病変の悪性度を早期に発見することで、様々な乳房異常の効果的かつタイムリーな治療が可能となります。世界的に毎年診断される乳がんの3分の1は微細なものであり、このレベルは、スクリーニングプログラムが普及し、MRIなどのより高度なモダリティが臨床的に可能な病変を検出するにつれて上昇します。MRIは、乳房画像の疑わしい異常所見を診断するための安全で正確な非外科的方法であり、治療計画を含む適切な意思決定に不可欠なものです。乳がんの罹患率の増加は、女性の間でこの病気に対する意識を高め、市場の成長に貢献すると予想されます。さらに、市場におけるスクリーニングや画像診断技術の増加も、市場の成長を促進すると期待されています。

セグメント別の展望

世界の乳房病変局在化市場は、タイプおよび用途に基づいて区分されます。タイプに基づき、市場はワイヤーローカライズ、ラジオアイソトープローカライズ、磁気ローカライズ、電磁ローカライズ、その他のローカライズに区分されます。さらに、用途に基づき、市場は乳房生検、乳房温存（ランペクトミー）、その他に細分化されます。このうち、乳房温存術は、世界的に女性の乳がん患者数が増加していることなどから、予測期間中、市場で大きなシェアを占めると予想されます。

乳房病変局在化の世界市場では、ワイヤーローカライゼーションサブセグメントが圧倒的なシェアを占めると予想されます。

乳房病変局在化システム市場において、予測期間中、ワイヤーローカライゼーション分野は大きな成長を遂げると予想されます。これは、乳がん患者の増加、技術的に進歩した製品の増加、製品の発売の増加といった要因によるものです。また、他の乳房病変局在化技術に比べ、安価で正確、かつ効果的であるなど、ワイヤーによる局在化法が提供する利点は、乳がん治療における採用率を高めると予想されます。この要因も、このセグメントの成長にプラスの影響を与えると予想されます。

地域別の展望

世界の乳房病変局在化市場は、北米（米国、カナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、中南米）を含む地域に基づきさらに細分化されています。また、ご要望に応じて、特定の地域や国レベルでの市場分析も可能です。このうち、アジア太平洋地域は、製品ポートフォリオの拡充、事業の多角化、低コスト化、ユーザー満足度の向上、乳房病変局在化法の信頼性向上などの戦略的取り組みを進めており、予測期間中の市場成長で大きなシェアを占めると予想されます。

乳房病変局在化法の世界市場では北米地域が圧倒的なシェアを占めると予測

予測期間中、北米が同市場において突出したシェアを占めると予想されます。乳がん患者の増加、強固なヘルスケアインフラ、乳がんに対する意識の高まりなどの要因が、乳房病変局在化市場の成長を後押ししています。乳がん患者の増加は、乳がんを治療するための診断や外科的処置の需要を高め、乳房病変局所化市場の成長に貢献すると思われます。さらに、同地域における製品認可の高まりは、同市場における局在化装置の可用性を高め、予測期間中の市場成長を促進すると予想されます。

市場プレイヤーの展望：

世界の乳房病変局在化市場に参入している主要企業は、Argon Medical Devices、Matek Medical Devices Technology Industry and Trade Inc.、Sterylab S.R.L.、Medax Medical Devices、その他です。市場プレイヤーは、市場での競争力を維持するために、M&A、パートナーシップ、コラボレーション、資金調達、新製品の発売など、さまざまな戦略を採用することで、市場の成長にかなり貢献しています。例えば、2022年7月、Merit Medical System社は、乳房腫瘍、生検部位、リンパ節をマーキングするための無線レーダー誘導型定位システム「SCOUT」の利点を実証するための市販後観察研究において最初の患者を登録しました。

目次

第1章 レポート概要

• 業界の現状分析と成長性の展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの見解と現在の市場動向
  • 主要な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 乳房病変局在化の世界市場：タイプ別
  • ワイヤーローカライゼーション
  • ラジオアイソトープローカライゼーション
  • 磁気ローカライゼーション
  • 電磁波ローカライゼーション
  • その他のローカライゼーション
• 乳房病変局在化の世界市場：使用目的別
  • 乳房生検
  • 乳房温存術（ルンペクトミー）
  • その他

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• Argon Medical Devices
• Becton, Dickinson and Co.
• Biomedical S.R.L
• Biopsybell S.R.L.
• C.R. Bard, Inc.
• CP Medical
• Devicor Medical Products Inc.
• Endomagnetics Ltd.
• Hologic Inc.
• IsoAid
• Leica Biosystems Nussloch GmbH
• Matek Medical Devices Technology Industry and Trade Inc.
• MDL SRL
• Medax Medical Devices
• Merit Medical Systems, Inc.
• Mermaid Medical A/S
• Molli Surgical Inc.
• Ranfac Corp.
• Sirius Medical Systems B.V.
• Sterylab S.R.L.
• SurgicEye GmbH
• Tsunami Medical S.R.L.
• Vigeo S.R.L.

LIST OF TABLES

• 1. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 2. GLOBAL WIRE BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL RADIOISOTOPE BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL MAGNETIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY RE-GION, 2022-2030 ($ MILLION)
• 5. GLOBAL ELECTROMAGNETIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
• 8. GLOBAL BREAST BIOPSY LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL BREAST CONSERVATION LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 13. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 14. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY US-AGE, 2022-2030 ($ MILLION)
• 15. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 16. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 17. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
• 18. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 19. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 20. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
• 21. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 22. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 23. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY US-AGE, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY TYPE, 2022 VS 2030 (%)
• 2. GLOBAL WIRE BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL RADIOISOTOPE BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL MAGNETIC BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL ELECTROMAGNETIC BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY USAGE, 2022 VS 2030 (%)
• 8. GLOBAL BREAST BIOPSY LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL BREAST CONSERVATION LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. US BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 13. CANADA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 14. UK BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 15. FRANCE BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 16. GERMANY BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 17. ITALY BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 18. SPAIN BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 19. REST OF EUROPE BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 20. INDIA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 21. CHINA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 22. JAPAN BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 23. SOUTH KOREA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 24. REST OF ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
• 25. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)

The global breast lesion localization market size was valued at $480 million in 2022, and is projected to reach $812 million by 2030, registering a CAGR of 7.8% during the forecast period (2023-2030). The global breast lesion localization market is expected to witness significant growth during the forecast period due to rising prevalence of breast cancer across the globe. Early detection of the malignancy of palpable and non-palpable breast lesions can result in effective and timely treatment of various breast abnormalities. One-third of breast cancers diagnosed each year globally are subtle, and this level rises as screening programs become more prevalent and more advanced modalities such as MRI detect more clinically potential lesions. It is a safe and accurate non-surgical method for diagnosing suspicious abnormal findings in breast images and is essential for proper decision making, including treatment planning. The rising incidence of breast cancer is creating awareness about the disease among women which is expected to contribute to the growth of the market. Further, the rise in the number of screening and imaging techniques in the market is also expected to propel the market growth.

Segmental Outlook:

The global breast lesion localization market is segmented based on the type and usage. Based on the type, the market is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization. Based on the usage, the market is further sub-segmented into breast biopsy, breast conservation (lumpectomy), and others. Among the usage, the breast conservation is expected to hold considerable share in the market over the forecast period owing to factors such as the rising number of breast cancer among the women globally.

The Wire Localization Sub-Segment is anticipated to Hold Prominent Share in the Global Breast Lesion Localization Market

The wire localization segment is expected to witness significant growth in the breast lesion localization systems market over the forecast period owing to factors such as the rising prevalence of breast cancer among the population, growing technologically advanced products, and rising product launches. The advantages offered by the wire localization method, such as being less expensive, more accurate, and more effective than other breast lesion localization techniques, are also expected to increase its adoption during breast cancer treatment. This factor is also expected to impact the growth of the segment positively.

Regional Outlooks:

The global breast lesion localization market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for particular region or country level as per the requirement. Among these, the Asia-Pacific regional market is expected to hold significant share in the market growth over the forecast period owing to the factors such as market players are taking strategic initiatives on widening product portfolio, diversified business operations, lower costs, user satisfaction, and improve breast lesion localization Methods reliability.

The North America Region Is Expected To Hold Prominent Share in the Global Breast Lesion Localization Market

North America is expected to hold a prominent share in the market over the forecast period. The factors such as rising burden of breast cancer cases coupled with robust healthcare infrastructure and increasing awareness about breast cancer are propelling the growth of the breast lesion localization market. The rising breast cancer cases rise the demand for diagnostics and surgical procedures for treating breast cancer which will contribute to the breast lesion localization market over the years. Furthermore, the rising product approvals in the region increase the availability of localization devices in the market which is anticipated to boost market growth over the forecast period.

Market Players Outlook:

The major companies serving the global breast lesion localization market include Argon Medical Devices, Matek Medical Devices Technology Industry and Trade Inc., Sterylab S.R.L., Medax Medical Devices, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2022, Merit Medical System enrolled the first patient in a post-market, observational study to demonstrate the benefits of SCOUT, a wireless, radar-guided localization system for marking breast tumors, biopsy sites, and lymph nodes.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Breast Lesion Localization Market by Type
  • 4.1.1. Wire Localization
  • 4.1.2. Radioisotope Localization
  • 4.1.3. Magnetic Localization
  • 4.1.4. Electromagnetic Localization
  • 4.1.5. Other Localization
• 4.2. Global Breast Lesion Localization Market by Usage
  • 4.2.1. Breast Biopsy
  • 4.2.2. Breast Conservation (Lumpectomy)
  • 4.2.3. Others

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Argon Medical Devices
• 6.2. Becton, Dickinson and Co.
• 6.3. Biomedical S.R.L
• 6.4. Biopsybell S.R.L.
• 6.5. C.R. Bard, Inc.
• 6.6. CP Medical
• 6.7. Devicor Medical Products Inc.
• 6.8. Endomagnetics Ltd.
• 6.9. Hologic Inc.
• 6.10. IsoAid
• 6.11. Leica Biosystems Nussloch GmbH
• 6.12. Matek Medical Devices Technology Industry and Trade Inc.
• 6.13. MDL SRL
• 6.14. Medax Medical Devices
• 6.15. Merit Medical Systems, Inc.
• 6.16. Mermaid Medical A/S
• 6.17. Molli Surgical Inc.
• 6.18. Ranfac Corp.
• 6.19. Sirius Medical Systems B.V.
• 6.20. Sterylab S.R.L.
• 6.21. SurgicEye GmbH
• 6.22. Tsunami Medical S.R.L.
• 6.23. Vigeo S.R.L.